suppress [ftcn]    
Effect [qlco]    
Hepatitis B Virus [virs]    
Hepatocellular carcinoma [neop]    
Background [cnce]    
Aim [idcn]    
investigate [ftcn]    
Efficacy [qlco]    
Effect [qlco]    
Hepatitis B Virus-Related Hepatocellular Carcinoma [neop]    
patient [podg]    
Method [inpr]    
Nucleoside [nnon]    
Hepatitis B, Chronic [dsyn]    
patient [podg]    
TREAT [topp]    
entecavir 0.5 MG [clnd]    
/day [tmco]    
less [inpr]    
month [tmco]    
71 [inpr]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Start [tmco]    
treatment [ftcn]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Not [ftcn]    
Non [ftcn]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Compare [acty]    
Anti-Viral Response [orgf]    
Two [qnco]    
Group [idcn]    
Evaluable [ftcn]    
Effect [qlco]    
Clinical [qlco]    
Outcome [ftcn]    
TREAT [topp]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Result [ftcn]    
Hepatocellular carcinoma [neop]    
Non [ftcn]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
Similar [qlco]    
Cumulative [qlco]    
Rate [acty]    
NEG [qlco]    
Normal [resa]    
Hepatitis E antigen [imft]    
Loss [qnco]    
year [tmco]    
97 [inpr]    
/40 [tmco]    
treatment [ftcn]    
month [tmco]    
Decrease [qnco]    
Mean [qnco]    
Model [inpr]    
End Stage Liver Disease [dsyn]    
Score [qnco]    
patient [podg]    
Cirrhosis [dsyn]    
Hepatocellular carcinoma [neop]    
5 6 [fndg]    
71 [inpr]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Curative [cnce]    
Therapies [topp]    
Hepatectomies [topp]    
Six [qnco]    
radiofrequency ablation [topp]    
55 [inpr]    
Remaining [qlco]    
patient [podg]    
Receive [qlco]    
Transarterial Chemoembolization [topp]    
treatment [ftcn]    
subgroup [virs]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Receive [qlco]    
Curative treatment [fndg]    
patient [podg]    
Serum [bdsu]    
NEG [qlco]    
week [tmco]    
Better [qlco]    
Overall [inpr]    
Survival [acty]    
Not [ftcn]    
Recurrence free survival [fndg]    
Not [ftcn]    
Conclusion [idcn]    
First [qnco]    
Line [spco]    
Effect [qlco]    
Hepatitis B, Chronic [dsyn]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Hepatic function [ortf]    
Hepatitis B Virus-Related Hepatocellular Carcinoma [neop]    
patient [podg]    
Early [tmco]    
virologic [ftcn]    
Response [orga]    
prognostic [inpr]    
Improved [qlco]    
Survival [acty]    
Following [tmco]    
Curative [cnce]    
Therapies [ftcn]    
Hepatitis B Virus-Related Hepatocellular Carcinoma [neop]    
